1. Headline
  1. Headline
updated 5/10/2012 4:46:47 PM ET 2012-05-10T20:46:47

Advisers to government health regulators have recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.

A panel of expert advisers to the Food and Drug Administration voted 18-4 to recommend approval of lorcaserin, developed by Arena Pharmaceuticals Inc. They concluded that its benefits "outweigh the potential risks when used long term" in overweight and obese people. One panel member abstained from voting.

Lorcaserin is one of three experimental weight-loss drugs whose developers have been trying for a second time to get approved, after the FDA shot them all down in 2010 or early 2011.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

More on TODAY.com

  1. Mark Winans

    ‘It’s a miracle:’ Oregon dog survives 150-foot fall

    10/23/2014 9:08:40 PM +00:00 2014-10-23T21:08:40
  1. New York checks suspected Ebola patient

    A health care worker who recently returned from West Africa is being isolated and checked for Ebola virus at New York’s Bellevue Hospital, city health officials said Thursday.

    10/23/2014 7:47:58 PM +00:00 2014-10-23T19:47:58
  1. Getty Images file

    Conan O'Brien gets zinged by Madeleine Albright in epic Twitter

    10/23/2014 11:50:22 PM +00:00 2014-10-23T23:50:22
  1. Reports: ‘I am mad at our son,' says Ottawa shooter’s mom

    The mother of the Ottawa parliament attack gunman said Thursday she was crying for the victims of the shooting, not her son, according to The Associated Press.

    10/23/2014 3:51:20 PM +00:00 2014-10-23T15:51:20